New study aims to perfect antibiotic dosing for newborns
NCT ID NCT07460349
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the current dosing of the antibiotic gentamicin is safe and effective for newborns up to 7 days old who have early-onset sepsis. Researchers will measure drug levels in the blood and check for kidney or hearing problems. The goal is to confirm that giving the dose less often works best and to create a standard guideline for hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY ONSET SEPSIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital: London Health Sciences Centre
RECRUITINGLondon, Ontario, N6A 5W9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.